Bluejay Diagnostics Statistics
Total Valuation
BJDX has a market cap or net worth of $1.00 million. The enterprise value is -$1.89 million.
Important Dates
The last earnings date was Tuesday, May 13, 2025, after market close.
| Earnings Date | May 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BJDX has 554,012 shares outstanding.
| Current Share Class | 554,012 |
| Shares Outstanding | 554,012 |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +5.15% |
| Owned by Insiders (%) | 0.11% |
| Owned by Institutions (%) | 6.77% |
| Float | 184,916 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.27 |
| P/TBV Ratio | 0.27 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.71, with a Debt / Equity ratio of 0.05.
| Current Ratio | 2.71 |
| Quick Ratio | 2.37 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -8.06 |
Financial Efficiency
Return on equity (ROE) is -200.56% and return on invested capital (ROIC) is -106.89%.
| Return on Equity (ROE) | -200.56% |
| Return on Assets (ROA) | -80.05% |
| Return on Invested Capital (ROIC) | -106.89% |
| Return on Capital Employed (ROCE) | -167.38% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.93M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.08% in the last 52 weeks. The beta is 0.40, so BJDX's price volatility has been lower than the market average.
| Beta (5Y) | 0.40 |
| 52-Week Price Change | -99.08% |
| 50-Day Moving Average | 2.72 |
| 200-Day Moving Average | 5.15 |
| Relative Strength Index (RSI) | 44.83 |
| Average Volume (20 Days) | 341,013 |
Short Selling Information
The latest short interest is 94,704, so 17.09% of the outstanding shares have been sold short.
| Short Interest | 94,704 |
| Short Previous Month | 38,307 |
| Short % of Shares Out | 17.09% |
| Short % of Float | 51.21% |
| Short Ratio (days to cover) | 0.03 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -6.63M |
| Pretax Income | -9.74M |
| Net Income | -20.48M |
| EBITDA | -6.56M |
| EBIT | -6.63M |
| Earnings Per Share (EPS) | -$63.91 |
Full Income StatementBalance Sheet
The company has $3.12 million in cash and $187,374 in debt, giving a net cash position of $2.93 million or $5.29 per share.
| Cash & Cash Equivalents | 3.12M |
| Total Debt | 187,374 |
| Net Cash | 2.93M |
| Net Cash Per Share | $5.29 |
| Equity (Book Value) | 3.87M |
| Book Value Per Share | 6.98 |
| Working Capital | 2.26M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$6.70 million and capital expenditures -$271,350, giving a free cash flow of -$6.98 million.
| Operating Cash Flow | -6.70M |
| Capital Expenditures | -271,350 |
| Free Cash Flow | -6.98M |
| FCF Per Share | -$12.59 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |